Shopping Cart
- Remove All
- Your shopping cart is currently empty
UVI 3003 is a highly selective antagonist of the retinoid X receptor, inhibiting Xenopus and human RXRα in Cos7 cells with IC50 values of 0.22 μM and 0.24 μM, respectively.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $30 | In Stock | |
2 mg | $44 | In Stock | |
5 mg | $68 | In Stock | |
10 mg | $122 | In Stock | |
25 mg | $255 | In Stock | |
50 mg | $428 | In Stock | |
100 mg | $639 | In Stock | |
1 mL x 10 mM (in DMSO) | $78 | In Stock |
Description | UVI 3003 is a highly selective antagonist of the retinoid X receptor, inhibiting Xenopus and human RXRα in Cos7 cells with IC50 values of 0.22 μM and 0.24 μM, respectively. |
Targets&IC50 | RXRα:0.22 μM(Xenopus RXRα, in Cos7 cells), RXRα:0.24 μM(Human RXRα, in Cos7 cells) |
In vitro | UVI3003 fully activates xPPARγ (EC50: 12.6 μM) and is almost completely inactive on hPPARγ and mPPARγ. UVI 3003 causes a 65.4% difference in EECD34 cell fusion and desmin expression. UVI 3003 (10 μM) does not change the proliferation rate of extraocular muscles (EOM)-derived or LEG-derived EECD34 cells [1][2]. |
Molecular Weight | 436.58 |
Formula | C28H36O4 |
Cas No. | 847239-17-2 |
Smiles | CCCCCOc1cc2c(cc1-c1cc(\C=C\C(O)=O)ccc1O)C(C)(C)CCC2(C)C |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (229.05 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.